SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001108205-24-000032
Filing Date
2024-05-07
Accepted
2024-05-07 08:02:29
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K cris-20240507.htm   iXBRL 8-K 30022
2 EX-99.1 a1q24earningspressrelease.htm EX-99.1 65781
6 image_0.jpg GRAPHIC 13933
  Complete submission text file 0001108205-24-000032.txt   252469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20240507.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20240507_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20240507_pre.xml EX-101.PRE 13054
19 EXTRACTED XBRL INSTANCE DOCUMENT cris-20240507_htm.xml XML 2912
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 24919695
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)